Improvement in Left Ventricular Systolic and Diastolic Performance During Ranolazine Treatment in Patients With Stable Angina

Ranolazine as a Cardioplegia Additive Improves Recovery of Diastolic Function in Isolated Rat Hearts

(2009) H. Hwang et al.   CIRCULATION

A Novel Mechanism for the Treatment of Angina, Arrhythmias, and Diastolic Dysfunction: Inhibition of Late INa Using Ranolazine

(2009) Lars S Maier   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Ranolazine as an Adjunct to Cardioplegia: A Potential New Therapeutic Application

(2009) Hyosook Hwang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

The Late Na+ Current (INa) Inhibitor Ranolazine Attenuates Effects of Palmitoyl-L-Carnitine to Increase Late INa and Cause Ventricular Diastolic Dysfunction

(2009) Y. Wu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Ranolazine: New Paradigm for Management of Myocardial Ischemia, Myocardial Dysfunction, and Arrhythmias

(2008) Peter H. Stone   CARDIOLOGY CLINICS

Ranolazine Shortens Repolarization in Patients with Sustained Inward Sodium Current Due to Type-3 Long-QT Syndrome

(2008) ARTHUR J. MOSS et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Ranolazine Inhibits An Oxidative Stress-induced Increase in Myocyte Sodium and Calcium Loading During Simulated-demand Ischemia

(2008) Xiu Q Zhang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts — Role of late sodium current and intracellular ion accumulation

(2008) Samuel Sossalla et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Late sodium current inhibition as a new cardioprotective approach

(2008) Sharon L. Hale et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY